Andreas D. Hartkopf
Otfried Müller Str. 10
Tuebingen, BW 72076, Germany
Tuebingen, BW 72076, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 281 publications
Clinical Relevance of Post-Treatment Circulating Tumor DNA Detection in Early Breast Cancer Using a Tissue-Free Epigenomic Assay: A 2-Year Landmark Analysis.
Journal: JCO precision oncology
Published: September 04, 2026
Survival Analysis of the WSG TP-II Trial: Neoadjuvant Trastuzumab and Pertuzumab Plus Endocrine Therapy Versus Chemotherapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 18, 2026
AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer-2026 Update.
Journal: Breast (Edinburgh, Scotland)
Published: April 29, 2026
Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 20, 2026
AGO Breast Committee recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2026.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: March 24, 2026
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2026.
Journal: Breast care (Basel, Switzerland)
Published: March 08, 2026
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2026.
Journal: Breast care (Basel, Switzerland)
Published: March 05, 2026
The adverse prognostic impact of reduced chemotherapy dose intensity appears attenuated in early breast cancer patients with treatment-relevant neutropenia: a retrospective cohort study.
Journal: Archives of gynecology and obstetrics
Published: December 12, 2025
Impact of chemotherapy dose capping on treatment intensity and survival in early breast cancer patients with high body surface area.
Journal: Archives of gynecology and obstetrics
Published: December 12, 2025
PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry.
Journal: NPJ breast cancer
Published: November 29, 2025
Last Updated: 09/26/2026